NDLI: An Effective Therapy to Painful Bone Metastases: Cryoablation Combined with Zoledronic Acid

Content Provider	Springer Nature Link
Author	Li, Fenqiang Wang, Wenhui Li, Li Chang, Yaowen Su, Dongjun Guo, Gang He, Xuewen Li, Mingxiang
Copyright Year	2014
Abstract	Approximately half or more of patients diagnosed with late malignant tumors may suffer from metastatic bone pain, effective palliation of pain becomes an important part of comprehensive therapy for malignant tumors. In this study, we examined the efficacy and safety of the combined regimen of cryoablation and zoledronic acid in patients of bone metastatic pain. A total of 84 subjects were randomly divided into three groups, and underwent treatments of cryoablation plus zoledronic acid, cryoablation alone, zoledronic acid alone between June 2009 and March 2012. Patients responses had been assessed for a total of 6 months by using the Brief Pain Inventory (BPI)-Short Form. The results showed that the mean response of worst and average pain significantly dropped at week 2 (all P < 0.05) in group with cryoablation treatment but at week 4 (all P < 0.05) in group with zoledronic acid treatment. While between week 16 and week 24, zoledronic acid treatments showed more durable response to worst and average pain compared to cryoablation (all P < 0.05). Cryoablation plus zoledronic acid regimen showed significant drop in worst and average pain between week 1 and week 4 compared to zoledronic acid alone (all P < 0.05) and more durable effect on bone metastatic pain between week 12 and week 24 than cryoablation alone (all P < 0.05). Additionally, no serious adverse effects and complication were observed by this combination use. In conclusion, cryoablation combined with zoledronic acid was safe and effective regimen and showed its superiority of fast response and durable effect on painful bone metastases.
Starting Page	885
Ending Page	891
Page Count	7
File Format	PDF
ISSN	12194956
Journal	Pathology & Oncology Research
Volume Number	20
Issue Number	4
e-ISSN	15322807
Language	English
Publisher	Springer Netherlands
Publisher Date	2014-04-30
Publisher Place	Dordrecht
Access Restriction	Subscribed
Subject Keyword	Pain Bone metastases Cryoablation Zoledronic acid Combined therapy Efficacy Cancer Research Oncology Pathology Immunology Biomedicine general
Content Type	Text
Resource Type	Article
Subject	Cancer Research Pathology and Forensic Medicine Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

An effective therapy to painful bone metastases: cryoablation combined with zoledronic acid.

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases

Zoledronic acid (ZOMETA): a significant improvement in the treatment of Bone metastases

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients

Characterization of the Attenuation of Breast Cancer Bone Metastasis in Mice by Zoledronic Acid Using $^{99m}$Tc bone Scintigraphy

Prognostic Factors and Survival of Renal Clear Cell Carcinoma Patients with Bone Metastases

Successful Treatment of Solitary Bone Metastasis of Non-Small Cell Lung Cancer with Bevacizumab and Hyperthermia

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

An Effective Therapy to Painful Bone Metastases: Cryoablation Combined with Zoledronic Acid

Similar Documents

An effective therapy to painful bone metastases: cryoablation combined with zoledronic acid.

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases

Zoledronic acid (ZOMETA): a significant improvement in the treatment of Bone metastases

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients

Characterization of the Attenuation of Breast Cancer Bone Metastasis in Mice by Zoledronic Acid Using $^{99m}$Tc bone Scintigraphy

Prognostic Factors and Survival of Renal Clear Cell Carcinoma Patients with Bone Metastases

Successful Treatment of Solitary Bone Metastasis of Non-Small Cell Lung Cancer with Bevacizumab and Hyperthermia

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma

An Effective Therapy to Painful Bone Metastases: Cryoablation Combined with Zoledronic Acid